 FSD Pharma Inc is to buy Canada-based specialty psychedelic pharma group Lucid Psycheceuticals Inc in a stock deal worth around US9 million C11.3 million. The life sciences holding company said the acquisition provided it with new assets at the forefront of new medicine and represented a paradigm shift in its development. 